Caffeic acid phenethyl ester (CAPE) may be a promising adjuvant treatment in gastric cancer

J Clin Gastroenterol. 2007 Nov-Dec;41(10):871-3. doi: 10.1097/MCG.0b013e31806b5938.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Adjuvants, Pharmaceutic / pharmacology
  • Adjuvants, Pharmaceutic / therapeutic use*
  • Caffeic Acids / pharmacology
  • Caffeic Acids / therapeutic use*
  • Helicobacter Infections / complications
  • Helicobacter Infections / drug therapy
  • Helicobacter Infections / microbiology
  • Helicobacter pylori / pathogenicity*
  • Humans
  • NF-kappa B / antagonists & inhibitors*
  • NF-kappa B / metabolism
  • Phenylethyl Alcohol / analogs & derivatives*
  • Phenylethyl Alcohol / pharmacology
  • Phenylethyl Alcohol / therapeutic use
  • Stomach Neoplasms / drug therapy*
  • Stomach Neoplasms / metabolism
  • Stomach Neoplasms / microbiology

Substances

  • Adjuvants, Pharmaceutic
  • Caffeic Acids
  • NF-kappa B
  • caffeic acid phenethyl ester
  • Phenylethyl Alcohol